CFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells;Kutanes anaplastisches großzelliges Lymphom Apoptoseresistenz durch CD30-induzierte cFLIP-Expression

Pathologe

Volumn 31, Issue SUPPL. 2, 2010, Pages 193-198

  Hirsch, B ^a   Braun, F K ^a   Al Yacoub, N ^a   Assaf, C ^a   Kadin, M E ^b   Sterry, W ^a   Eberle, J ^a   Durkop H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RW Medical Center   (United States)

Author keywords

"Nuclear factor kappa B"; Anti apoptotic; CD30; CFLIP; Signal transduction

Indexed keywords

CD30 ANTIGEN; CFLAR PROTEIN, HUMAN; FAS ANTIGEN; FAS PROTEIN, HUMAN; FLICE INHIBITORY PROTEIN; MESSENGER RNA;

APOPTOSIS; ARTICLE; CUTANEOUS T CELL LYMPHOMA; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LARGE CELL LYMPHOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR; TUMOR CELL LINE; UPREGULATION;

ANTIGENS, CD30; ANTIGENS, CD95; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, T-CELL, CUTANEOUS; RECEPTOR CROSS-TALK; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; UP-REGULATION;

EID: 79953238658     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1372-4     Document Type: Article

References (15)

1. Stein H, Mason DY, Gerdes J et al (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848-858
2. Hirsch B, Brauer J, Fischdick M et al (2009) Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivo. Curr Drug Targets 10:110-117
3. Hubinger G, Muller E, Scheffrahn I et al (2001) CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299. Oncogene 20:590-598
4. Hirsch B, Hummel M, Bentink S et al (2008) CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. Am J Pathol 172:510-520
5. Scaffidi C, Kirchhoff S, Krammer PH, Peter ME (1999) Apoptosis signaling in lymphocytes. Curr Opin Immunol 11:277-285
6. Bagnoli M, Canevari S, Mezzanzanica D (2010) Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer. Int J Biochem Cell Biol 42:210-213
7. Guicciardi ME, Gores GJ (2009) Life and death by death receptors. FASEB J 23:1625-1637
8. Li-Weber M, Krammer PH (2003) Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin Immunol 15:145-157
9. Bartlett NL, Younes A, Carabasi MH et al (2008) A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies. Blood 111:1848-1854
10. Mathas S, Lietz A, Anagnostopoulos I et al (2004) c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis. J Exp Med 199:1041-1052
11. Micheau O, Thome M, Schneider P et al (2002) The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 277:45162-45171
12. Foyil KV, Bartlett NL (2010) Anti-CD30 antibodies for Hodgkin lymphoma. Curr Hematol Malig Rep 5:140-147
13. Boll B, Hansen H, Heuck F et al (2005). The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis. Blood 106:1839-1842
14. Braun FK, Hirsch B, Al-Yacoub N et al (2010) Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. J Invest Dermatol 130:826-840
15. Rubinson DA, Dillon CP, Kwiatkowski AV et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406